Medco-FDA PGx Alliance Aims to Improve Rx Efficacy, Safety, Consider Label Updates

The FDA plans to use Medco’s large claims database to understand “the real-world application of a test,” inform pharmacogenomics assessments of drug safety and efficacy, and update drug labels with genetic risk information.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.